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Accepted 20 May 2011AbstractObjective: To report successful pregnancy outcomes in three cases of documented premature ovulation in intracytoplasmic sperm injection
(ICSI) cycles.
Case Report: Three cases of premature ovulation were noted during the oocyte retrieval procedures in in vitro fertilization (IVF)/ICSI cycles
with gonadotropin-releasing hormone antagonist protocol. Immature oocytes were aspirated from the remaining small and medium-sized
follicles with in vitro maturation performed in two cases. All three cases achieved successful pregnancy with documented live birth after ICSI.
Conclusion: This is the first ever report of successful pregnancy outcome after documented premature ovulation. Fertilizable oocytes and
successful pregnancies can still be obtained from the remaining small and medium-sized follicles after premature ovulation and used for ICSI.
Copyright  2012, Taiwan Association of Obstetrics & Gynecology. Published by Elsevier Taiwan LLC. All rights reserved.
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In the early days of in vitro fertilization (IVF), premature
ovulation was a common problem encountered during
controlled ovarian hyperstimulation (COH). Such event almost
invariably led to cycle cancellation because of the depletion of
limited number of dominant follicles. With the availability of
human menopausal gonadotropin (hMG) and recombinant
follicular stimulation hormone (rFSH), clinicians were able to
synchronize multiple follicular growth thus ensuring higher
successful retrieval and fertilization rate per IVF cycle.
Nevertheless, the positive pituitary feedback by rapidly
rising estradiol (E2) levels secreted by the stimulated follicles
can augment the risk of an early luteinizing hormone (LH)* Corresponding author. Department of Obstetrics and Gynecology, Mackay
Memorial Hospital, 92, Section 2, Chung San North Road, Taipei 10449,
Taiwan.
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doi:10.1016/j.tjog.2012.04.016surge associated with premature ovulation. Although the
development of gonadotropin-releasing hormone (GnRH)
agonists and antagonists has effectively lower the occurrence
of such incidents [1,2], they are still not completely eradicated.
Some institutes would propose cancellation of the cycle after
premature ovulation, believing that oocytes from the remain-
ing smaller follicles are incapable of fertilization. We here
present three cases of successful pregnancy outcome after
documented premature ovulation during IVF with intra-
cytoplasmic sperm injection (ICSI) cycles.
Case reportsCase 1A 28-year-old gravida 2, para 0 woman with a diagnosis of
polycystic ovary syndrome (PCOS) by Rotterdam criteria was
scheduled for IVF in our clinic after six failed attempts of
clomiphene with intrauterine insemination (IUI) treatment. Oncs & Gynecology. Published by Elsevier Taiwan LLC. All rights reserved.
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Mu¨llerian hormone (AMH) were 4.68 IU/L, 15.46 IU/L,
0.79 ng/mL, and 20.30 ng/mL respectively. Patient was pre-
treated with combined oral contraceptive pills for one cycle
prior to initiation of IVF. An antagonist protocol was selected
under the discretion of the attending physician. Controlled
ovarian hyperstimulation was initiated on cycle day 2 using
hMG (Menopur, Ferring, Italy) 150 IU/day for 4 days. On Day
6, the stimulation was switched to rFSH (Gonal-F, Merck
Serono, Geneva, Switzerland) only stimulation at 100 IU/day
for 6 days. Serum E2 level on the Day 10 was 407.05 pg/mL.
On Day 12 of the cycle, transvaginal ultrasound revealed
several antral follicles in each ovary, with the largest measured
15 mm. She started Cetrorelix acetate 0.25 mg/day (Cetrotide,
Merck Serono, Geneva, Switzerland) on the same day for 4
days, and dosages of hMG and rFSH were adjusted. E2 was
decreased to 152.47 pg/mL the day after she started Cetrorelix
treatment, 43.22 pg/mL the next day, and 182.42 pg/mL on the
third day. On cycle Day 16, 500 mcg of recombinant human
chorionic gonadotropin (r-hCG; Ovidrel, Merck Serono,
Geneva, Switzerland) was given for the final maturation after
two leading follicles reached greater than 18 mm in mean
diameter. LH, progesterone (P4), and E2 level measured on the
day of hCG injection was 0.5 mIU/mL, 0.96 ng/mL, and
855.86 pg/mL, respectively. Oocyte retrieval was performed
36 hours later. The nonvisualization of leading follicles and
the presence of multiple corpus luteum during the oocyte
retrieval process confirmed the occurrence of premature
ovulation. Six metaphase I (MI) oocytes from medium-sized
follicles ranging from 1.2w1.4 cm in diameter were
retrieved and placed in the fertilization medium (Quinn’s
Advantage Fertilization medium; SAGE IVF Inc. Trumbull,
CT, USA) overnight. Four oocytes reaching metaphase II were
chosen for micromanipulation with conventional ICSI on Day
1 after ovum retrieval, and assisted hatching with zona thin-
ning by laser was performed on Day 4 when four embryos
were obtained. All four embryos were transferred. The profiles
of the embryos were as follow: 6-cells-grade 1, 8-cells-grade
2, 8-cells-grade 4, and 6-cells-grade 4 according to the Veeck’s
classification [3]. The pregnancy with heartbeats was
demonstrated on the sixth gestational week. The pregnancy
continued until 36 weeks and a live female infant weighing
2452 gm was delivered spontaneously due to preterm labor.
No major sequelae were noted for this infant as of the date of
manuscript completion.Case 2Patient is a 34-year-old gravida 0, para 0 woman with
a diagnosis of primary infertility. The bilateral tubal occlusion
was confirmed during surgery for endometrioma. On baseline
evaluation, serum E2, P4, and AMH were 13.10 IU/L, 0.79 ng/
mL, and 1.75 ng/mL, respectively. Patient was pretreated with
combined oral contraceptive pills for one cycle prior to initiation
of IVF. An antagonist protocol was selected and controlled
ovulation hyperstimulation began on cycle Day 2 using hMG
225 IU/day and rFSH 450 IU/day for 7 days. On Day 9 of thecycle, transvaginal ultrasound revealed several small follicles in
each ovary, with only one leading follicle reaching the size of
14 mm. She started Cetrorelix acetate 0.25 mg/day on the same
day for 3 days, and ovarian stimulation was maintained with the
same dosage of hMG and rFSH. On cycle Day 12, three leading
follicles with the sizes of 20 mm, 19 mm, and 17 mm were seen
on the ultrasound. The final oocyte maturation was triggered on
Day 14 with 500 mcg of r-hCG. The P4, LH, and E2 levels
measured on the day of r-hCG injection were 1.60 ng/mL,
0.64 mIU/mL, and 1125 pg/mL, respectively. The non-
visualization of leading follicles and the presence of ample
cul-de-sac fluid during the procedure of oocyte retrieval
confirmed the occurrence of premature ovulation. Six MI
oocytes were obtained, and four underwent rescue in vitro
maturation over night and micromanipulation with ICSI was
performed on the Day 1 after ovum retrieval. Among them only
one progressed beyond 2 pronuclear stage (2PN) stage, and
a postovum retrieval Day-4 transfer was performed. The profile
of the embryo was 8-cells-grade 2. The pregnancy with heart-
beats was demonstrated on the 6th gestational week. The preg-
nancy continued until 37 weeks and a living male infant
weighing 4006 g was delivered by cesarean section with the
indication of breech presentation.Case 3A 41-year-old gravida 0, para 0 woman of primary infertility
with endometriosis and themale factor who had underwent three
unsuccessful IVF/ICSI cycles that showedpoor ovarian response
after COH began her fourth cycle of GnRH antagonist protocol.
Patient was pretreatedwith combined oral contraceptive pills for
one cycle prior to initiation of IVF. Controlled ovulation
hyperstimulation began on cycle Day 3 using hMG 150 IU/day
and rFSH 450 IU/day for 4 days. On Day 7 of the cycle, ultra-
sound revealed several small follicles in each ovary. She started
Cetrorelix acetate 0.25mg/day onDay 10 for 4 days, and ovarian
stimulation was maintained with adjusted dosage of hMG and
rFSH.OnDay 13of the cycle, 500mcgof r-hCGwas givenwhen
the leading follicle reached 20mm. P4 and E2 level measured on
the day of hCG injection was 1.88 ng/mL and 1198.85 pg/mL.
Three leading follicles disappeared and ample peritoneal fluid
was noted during oocyte retrieval. Microscopic examination of
the aspirated fluid from the posterior cul-de-sac revealed
a postmature oocyte, confirming ovulation. The other five
oocytes were retrieved from medium and small-sized follicles;
among them, four were metaphase II (MII) stage. ICSI were
performed on the MII oocytes and only two progressed beyond
2PN stage. The profiles of the transferred embryos were as
follows: 6-cells-grade 1, and 8-cells-grade 2. The pregnancy
with heartbeats was demonstrated on gestational Week 7. The
pregnancy continued until 38 weeks and a living male infant
weighing 3264 g was delivered by elective cesarean section.
Discussion
The literature regarding the outcome after premature
ovulation has been scarce. Rather, most research has been
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the occurrence of increased serum P4 levels on the day of hCG
administration with conflicting results. In a study by Cunha-
Filho and colleagues [4] that analyzed the factors related to
premature LH and progesterone rise in intrauterine insemi-
nation cycles, the authors concluded that these events cannot
be predicted utilizing clinical parameters normally employed,
such as ultrasound, serum E2 assay, or stimulation protocol.
Although many studies indicated that there is no direct rela-
tionship between P4 levels and pregnancy rates [5e10], others
have demonstrated that the pregnancy rate is negatively
correlated to serum progesterone levels [11e15]. A possible
explanation is that after premature luteinization, elevated
serum P4 may lead to a state of asynchrony between embryo
and endometrium for implantation [16], resulting in reduced
pregnancy rate. The same mechanism may be applied to the
events after premature ovulation. A recent large scale meta-
analysis by Bosch and others [17] has designated serum P4
levels greater than 1.5 ng/ml at the day of hCG administration
to be the threshold associated with lower ongoing pregnancy
rates following IVF/ICSI cycles, regardless of the type of
GnRH analogue used. A note of interest is that two out the
three cases in our study had a P4 level above such value
(1.60 ng/mL and 1.88 ng/mL).
Another scenario is when premature ovulation occurred
during early phase of ovarian stimulation. There are reported
cases of premature ovulation with continued ovarian stimula-
tion followed by successful retrieval and cryopreservation of
collected mature oocytes [18,19] in cancer and advanced-aged
patients, since time is the utmost important for such patient
population. Several authors have proposed a “LH receptor
theory” [19,20], which stated since the granulosa cells of the
small antral follicles do not express sufficient LH receptors to
be affected by patient’s premature LH surge, the cycle can be
rescued if ovarian stimulation was continued.
Occasionally, premature ovulation was noted close to or
during oocyte retrieval. It is unknown exactly how long the
human oocytes can remain “fertilizable” after ovulation, but
mouse models have demonstrated oocytes can retain their
fertilization capacity for as long as 4e6 hours post-ovulation
[21]. Therefore the aspiration of the free fluid within the
pelvic cavity can theoretically offer a chance of collecting the
ovulated oocytes. Previous studies have demonstrated that
ovulated oocytes collected from cul-de sac shared similar
fertilization rates as the ones collected from intact follicles, as
well as documented live birth resulting from embryo devel-
oped from the oocytes collected from cul-de-sac [22,23].
Therefore, another plausible management when encountering
premature ovulation is to aspirate the cul-de-sac fluid thor-
oughly in the hope of recovering the ovulated oocytes.
Conclusion
To the best our knowledge, this is the first ever report
addressing the pregnancy outcome from the oocytes of the
remaining small and medium-sized follicles after documented
premature ovulation during controlled ovarian hyperstimulation.In the face of such event, some institutes would opt for cancel-
lation of the ovum retrieval, fearing that oocytes from the
remaining small and medium sized follicles do not possess the
ability to undergo fertilization. From the present report, it is
evident that fertilization, even live birth, is attainable from the
oocytes of the smaller follicles after premature ovulation of the
leading follicles.
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